Table 3

Multimorbidity transitions across A&E and hospital admission interface over 3 years

Study groups*A&E episodesHospital admissions
01230123
N (%)N (%)N (%)N (%)N (%)N (%)N (%)N (%)
HT+ DM−26 019(68.6)8903 (23.5)2466 (6.5)548 (1.4)21 957 (54.0)10 443 (27.5)4223 (11.1)1313 (3.5)
DM+ HT−2733 (63.2)1154 (26.4)372 (8.4)96 (2.1)2343 (54.0)1192 (27.5)601 (13.8)204 (4.7)
HT and DM6168 (63.4)2581 (26.5)776 (8.0)210 (2.2)4800 (49.3)2888 (29.7)1456 (15.0)591 (6.1)
DM+ CHD−7048 (67.1)2580 (24.6)703 (6.7)170 (1.6)5766 (54.9)2993 (28.2)1403 (12.7)490 (4.2)
CHD+ DM−6223 (57.6)3175 (29.4)1133 (10.5)276 (2.6)4842 (44.8)3482 (32.2)1813 (16.8)670 (6.2)
DM and CHD1863 (52.1)1145 (32.0)436 (12.2)130 (3.6)1377 (38.5)1123 (31.4)721 (20.2)353 (9.9)
DM+ CKD−7440 (66.5)2761 (24.7)775 (6.9)205 (1.8)6083 (54.4)3142 (28.1)1438 (12.9)518 (4.6)
CKD+ DM−5137 (57.3)2733 (30.5)893 (10.0)195 (2.2)3923 (43.8)3056 (34.1)1502 (16.8)477 (5.3)
DM and CKD1471 (50.8)964 (33.3)364 (12.6)95 (3.3)1060 (36.6)938 (32.4)619 (21.4)277 (9.6)
COPD+ CHD−3013 (56.8)1568 (29.6)546 (10.3)177 (3.3)2443 (46.1)1665 (31.4)843 (15.9)353 (6.7)
CHD+ COPD−7267 (58.0)3689 (29.5)1261 (10.1)309 (2.5)5641 (45.0)3973 (31.7)2108 (16.8)804 (6.4)
COPD and CHD819 (44.2)631 (34.0)308 (16.6)97 (5.2)578 (31.2)632 (34.1)426 (23.0)219 (11.8)
COPD+ CHF−3519 (54.9)1940 (30.3)723 (11.3)223 (3.5)2810 (43.9)2018 (31.5)1102 (17.2)475 (7.4)
CHF+ COPD−1346 (46.7)990 (34.3)440 (15.3)108 (3.7)978 (33.9)996 (34.5)645 (22.4)265 (9.2)
CHF and COPD313 (41.5)259 (34.4)131 (17.4)51 (6.8)211 (28.0)279 (37.0)167 (22.1)97 (12.9)
CHF+ CKD−1173 (53.0)665 (30.0)295 (13.3)80 (3.6)884 (39.9)737 (33.3)414 (18.7)178 (8.0)
CKD+ CHF−6122 (58.7)3113 (29.9)981 (9.4)211 (2.0)4678 (44.9)3456 (33.1)1723 (16.5)570 (5.5)
CKD and CHF481 (33.4)595 (41.3)284 (19.7)80 (5.6)305 (21.4)538 (37.8)398 (27.9)184 (12.9)
  • *Minus sign indicates absence of disease and positive sign indicates presence.

  • A&E, accident and emergency; CHD, coronary heart disease; CHF, chronic heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HT, hypertension.